Clinical Trial

Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study

Study acronym: FIN-CARE
Completed
View on ClinicalTrials.gov →
Summary
This multicenter, cross-sectional observational study aims to evaluate the impact of financial toxicity on caregiver burden, quality of life, and emotional distress among hospitalized adult cancer patients. Participants will complete validated Turkish versions of the Zarit Caregiver Burden Scale, the EORTC QLQ-C30, and the Hospital Anxiety and Depression Scale (HADS). Financial toxicity will be assessed through indicators such as household income, treatment-related costs, and insurance coverage. Informed consent will be obtained from all participants. The study will not impose any financial burden on the participants or the hospital. Data collection is planned between August 1, 2025 and January 15, 2026 at three tertiary centers: Etlik City Hospital, Gazi University Faculty of Medicine, and Kocaeli University Faculty of Medicine in Turkey. The findings are expected to contribute to the development of targeted support strategies for patients and caregivers in oncology settings.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-16; most recent amendment 2026-02-19.
Status change: Recruiting → Completed 2026-02-19
Status change: Not Yet Recruiting → Recruiting 2025-08-18
Trial Details
NCT Number NCT07083271
Lead Sponsor Ankara Etlik City Hospital
Collaborators: Gazi University, Kocaeli University
Conditions Financial Toxicity, Cancer Patients
Enrollment 756 participants
Start Date 2025-08-01
Primary Completion 2025-10-22 (estimated)
Study Completion 2026-02-19 (estimated)
Updated on ClinicalTrials.gov 2026-02-20